![]() |
市場調查報告書
商品編碼
1597172
歐洲臨床參考實驗室市場預測至 2031 年 - 區域分析 - 按服務提供者(醫院、獨立和診所)和應用(實驗室醫學、臨床試驗等)Europe Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others) |
2023年歐洲臨床參考實驗室市值為134.3117億美元,預計2031年將達到216.700億美元;預計2023年至2031年複合年成長率為6.2%。
臨床試驗數量的增加推動了歐洲臨床參考實驗室市場
臨床試驗有助於評估新的治療或預防方法,例如新的藥物、飲食或醫療技術是否安全有效。這些試驗主要在藥物開發階段進行。根據歐洲藥品管理局統計,歐盟(EU)每年批准約4,000項臨床試驗,其中製藥業約佔60%。由於慢性病的盛行率不斷增加,臨床試驗的數量不斷增加,以開發各種有效的治療方法。臨床試驗正逐漸變得複雜,因為對研究型組織中發生的操作的正確執行和監督變得至關重要。研究型組織在開發產品時外包臨床試驗,以避免因執行不當而出現錯誤。參考實驗室以其積極主動的方式跟上科學技術的進步而聞名。參考實驗室迅速採用和整合新的診斷儀器、設備和技術,使他們能夠評估其潛在的應用和效益。臨床參考實驗室透過提供廉價且高效的全面臨床和比較測試菜單,幫助研究團隊成功開展專案。臨床參考實驗室收集並提供所需的樣本,並在其設施中進行必要的測試。這意味著所有服務都可以在同一個屋簷下使用。 Vimta Labs Ltd、Regional Pathology Services 和 Boca Bio 提供商業臨床試驗服務。因此,臨床試驗數量的增加正在推動臨床參考實驗室市場的成長。
歐洲臨床參考實驗室市場概況
癌症、心血管疾病、神經系統疾病和傳染病是德國臨床試驗中最常研究的疾病。臨床研究受惠於德國完善的交通、通訊、能源和公共服務基礎設施。根據美國國立衛生研究院 2023 年 12 月發表的一篇文章,德國約有 400 萬人患有罕見疾病。罕見疾病具有複雜的臨床模式。此類疾病的治療需要加速試驗和快速追蹤臨床結果。這就是參考實驗室發揮關鍵作用的地方。 2023 年 1 月,Premier Research 與 CENTOGENE 合作,降低罕見疾病臨床開發的風險。 Premier Research 在罕見疾病產品開發方面的廣泛專業知識將得到 CENTOGENE 生物資料庫和多組學參考實驗室產生的先進見解的支持。此外,由於慢性病毒性疾病的盛行率不斷上升,以及為病毒治療領域生產新分子以滿足未滿足條件的需求不斷成長,德國對抗感染藥物的需求正在顯著成長。由於上述因素,預計該國市場將大幅成長。
歐洲臨床參考實驗室市場收入及 2031 年預測(百萬美元)
歐洲臨床參考實驗室市場細分
歐洲臨床參考實驗室市場按服務提供者、應用程式和國家分類。
根據服務提供者,歐洲臨床參考實驗室市場分為醫院型、獨立型和診所型。 2023 年,醫院細分市場佔據最大的市場。
從應用來看,歐洲臨床參考實驗室市場分為檢驗醫學、臨床試驗等。 2023 年,檢驗醫學領域佔據最大的市場佔有率。
依國家/地區分類,歐洲臨床參考實驗室市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2023 年,德國在歐洲臨床參考實驗室市場佔有率中佔據主導地位。
Sonic Healthcare Ltd、UNILABS、Laboratory Corp of America Holdings、Quest Diagnostics Inc、SYNLAB International GmbH 和 Myraid Genetics Inc 是歐洲臨床參考實驗室市場上的一些領先公司。
The Europe clinical reference laboratory market was valued at US$ 13,431.17 million in 2023 and is expected to reach US$ 21,670.00 million by 2031; it is estimated to register a CAGR of 6.2% from 2023 to 2031.
Increasing Number of Clinical Trials Drives Europe Clinical Reference Laboratory Market
Clinical trials assist in evaluating whether a new treatment or prevention method, such as a new medicine, diet, or medical technology, is safe and effective. The trials are primarily conducted during the drug development phase. According to the European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are approved annually, with the pharmaceutical industry accounting for roughly 60%. Due to the growing prevalence of chronic diseases, the number of clinical trials is increasing to develop various effective treatments. Clinical trials are gradually becoming complex procedures, because proper execution and oversight of the operations occurring in research-based organizations have become crucial. Research-based organizations are outsourcing clinical trials while developing their products to avoid errors due to improper execution. Reference laboratories are well-known for their proactive approach to keeping up with scientific and technological advancements. Reference labs promptly adopt and integrate new diagnostic instruments, equipment, and techniques, allowing them to evaluate their potential applications and benefits. Clinical reference labs help research teams successfully conduct their projects by providing a comprehensive menu of clinical and comparative testing performed inexpensively and efficiently. Clinical reference labs collect and provide the required samples and perform the necessary testing at their facility. That means all the services are available under one roof. Vimta Labs Ltd, Regional Pathology Services, and Boca Bio provide commercial clinical trial services. Thus, the increasing number of clinical trials is driving the clinical reference laboratory market growth.
Europe Clinical Reference Laboratory Market Overview
Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure. According to an article published by the National Institutes of Health in December 2023, ~4 million people had a rare disease in Germany. Rare diseases have complex clinical patterns. Treatments for such diseases need accelerated trials and fast-track clinical outcomes. This is where reference laboratories play a crucial role. In January 2023, Premier Research partnered with CENTOGENE to de-risk rare disease clinical development. Premier Research's extensive expertise in rare disease product development will be supported by advanced insights generated by the CENTOGENE Biodatabank and multiomic reference laboratories. Moreover, the demand for anti-infective agents in Germany is growing significantly, attributed to the increasing prevalence of chronic viral diseases and the growing demand to produce new molecules for viral therapeutic areas to fulfill unmet conditions. The market is expected to grow significantly in the country due to the abovementioned factors.
Europe Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)
Europe Clinical Reference Laboratory Market Segmentation
The Europe clinical reference laboratory market is categorized into service provider, application, and country.
Based on service provider, the Europe clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.
In terms of application, the Europe clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.
By country, the Europe clinical reference laboratory market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe clinical reference laboratory market share in 2023.
Sonic Healthcare Ltd, UNILABS, Laboratory Corp of America Holdings, Quest Diagnostics Inc, SYNLAB International GmbH, and Myraid Genetics Inc are some of the leading companies operating in the Europe clinical reference laboratory market.